Articles | EuroIntervention

10.4244/EIJV9I4A80 • Aug 23, 2013

Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI)

Kajiya T, Liang M, Sharma R, Lee C-H, Chan M, Tay E, Chan K-H, Tan H-C, Low A

free

10.4244/EIJV9I4A81 • Aug 23, 2013

First-in-man intracoronary use of the Trevo® Pro 4 mechanical thrombectomy device for the retrieval of large intracoronary thrombus in patients with acute coronary syndromes

van de Hoef TP, Woudstra P, Sprengers M, Koch K, Majoie C, Piek J, de Winter R

free

10.4244/EIJV9I3A48 • Jul 26, 2013

The Journal Citation Reports® Impact Factor: annual results 2012

Cummins P, Serruys PW

free

10.4244/EIJV9I3A49 • Jul 26, 2013

Personalised antiplatelet therapy: are we ready for prime time? Data from China

Li J, Huo Y

free

10.4244/EIJV9I3A50 • Jul 26, 2013

Clinical assessment, platelet reactivity measurement or genetic testing after acute coronary syndrome? What benefits the patient?

Keßler M, Rottbauer W, Koenig W

free

10.4244/EIJV9I3A52 • Jul 26, 2013

Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Meredith I, Verheye S, Weissman N, Barragan P, Scott D, Valdés Chávarri M, West N, Kelbæk H, Whitbourn R, Walters D, Kubica J, Thuesen L, Masotti M, Banning A, Sjogren I, Stables R, Allocco DJ, Dawkins K

free

10.4244/EIJV9I3A53 • Jul 26, 2013

The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation

Liang Z-Y, Han Y, Zhang X-L, Li Y, Yan C-H, Kang J

free

10.4244/EIJV9I3A54 • Jul 26, 2013

Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trial

Jiménez-Quevedo P, Hernando L, Gomez-Hospital J, Iñiguez A, San Román A, Alfonso F, Hernández-Antolín R, Angiolillo D, Banuelos C, Escaned J, Gonzalo N, Fernandez C, Macaya C, Sabaté M

free

10.4244/EIJV9I3A55 • Jul 26, 2013

Long-term comparison of everolimus-eluting and biolimus-eluting stents

Puricel S, Oberhänsli M, Guntern P, Lehmann S, Goy J-J, Arroyo D, Villeneuve H, Baeriswyl G, Stauffer J-C, Togni M, Cook S

free

10.4244/EIJV9I3A56 • Jul 26, 2013

Full conversion from transfemoral to transradial approach for percutaneous coronary interventions results in a similar success rate and a rapid reduction of in-hospital cardiac and vascular major events

Dangoisse V, Guedes A, Gabriel L, Jamart J, Chenu P, Marchandise B, Schroeder E

free

10.4244/EIJV9I3A57 • Jul 26, 2013

Incidence, time course and predictors of early vs. late target lesion revascularisation after everolimus-eluting stent implantation: a SPIRIT V substudy

Niccoli G, Stuteville M, Sudhir K, Li D, Montone R, Bolognese L, Grube E

free

10.4244/EIJV9I3A58 • Jul 26, 2013

The impact of gender on fractional flow reserve measurements

Fineschi M, Guerrieri G, Orphal D, Palmerini E, Munzel T, Warnholtz A, Pierli C, Gori T

free

10.4244/EIJV9I3A59 • Jul 26, 2013

Gender differences in patients undergoing TAVI: a multicentre study

D’ascenzo F, Gonella A, Moretti C, Omedè P, Salizzoni S, La Torre M, Giordana F, Barbanti M, Ussia G, Brambilla N, Bedogni F, Gaita F, Tamburino C, Sheiban I

free

10.4244/EIJV9I3A60 • Jul 26, 2013

Panasewicz A, Pedersen S, Veenhuis S, Oemrawsingh R, van der Giessen WJ, van Geuns R, Regar E, de Jaegere P, Serruys PW, van Domburg R

free

10.4244/EIJV9I3A61 • Jul 26, 2013

Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study

Marchese N, Pacilli M, Inchingolo V, Fanelli F, Loperfido F, Vigna C

free